Arcadia Biosciences Inc. (RKDA)
Market Closed
15 Oct, 08:00 PM
$
0. 20
+0
+1.2438%
Pre Market
$
-0.01 -4.226% 0. 19
314.88K Market Cap
- P/E Ratio
- Div Yield
692,947 Volume
-9.72 Eps
$ 0.2
Previous Close Investors:
Want to track RKDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcadia Biosciences Inc. (RKDA) Statistics
Valuation metrics
Market Cap 314.88K
Enterprise value -3.77M
Trailing P/E (ttm) -0.03
Forward P/E -0.84
PEG ratio 0
Price/Sales (ttm) 0.09
Price/Book (mrq) 0.57
Enterprise Value/Revenue -0.79
Enterprise Value/EBITDA 0.34
Overview
Shares outstanding 1.37M
Float 2.05M
Shares short 6.34K
% Held by insiders 0.01%
% Held by institutions 0.02%
Average volume (10 days) 390.2K
Average volume (90 days) 59.73K
Price summary
52-Week low 0.16
52-Week high 5.63
Beta 0.52
50-Day moving average 0.26
200-Day moving average 1.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 1 Mar 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -2.35%
Operating margin -0.86%
Operational effectiveness
Return on assets -1.89%
Return on equity -3.4%
Income Statement
Revenue (ttm) 4.86M
Revenue per share (ttm) 3.47
Quarterly revenue growth (yoy) -0.26%
Gross profit (ttm) 1.75M
EBITDA -5.22M
Net income to common (ttm) -2.34M
Diluted EPS (ttm) -8.14
Quarterly earnings growth (yoy) -0.26%
Balance Sheet
Total cash (mrq) 4.56M
Total cash per share (mrq) 3.05
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.49%
Book value per share (mrq) 0.46
Cash Flow
Cash flow statement -4.74M
Levered free cash flow (LFCF) 721.75K
2026 © Marketlog. All Rights Reserved.
